Klin Farmakol Farm. 2020;34(2):56-62 | DOI: 10.36290/far.2020.012

Laboratory methods in therapeutic drug monitoring

Hana Brozmanová
Oddělení klinické farmakologie, Ústav laboratorní diagnostiky, Fakultní nemocnice Ostrava
Ústav klinické farmakologie, Lékařská fakulta, Ostravská univerzita, Ostrava

An important part of therapeutic drug monitoring are laboratory methods used to determine the concentration of drugs in the whole blood of serum, plasma, or other biological matrices. The article provides an overview of routine analytical methods and the gradually increasing importance of liquid chromatography with mass detection in the analysis of drugs.

Keywords: immunoassay, liquid chromatography, mass detection, validation.

Published: July 16, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Brozmanová H. Laboratory methods in therapeutic drug monitoring. Klin Farmakol Farm. 2020;34(2):56-62. doi: 10.36290/far.2020.012.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Grundmann M, Kacířová I. Význam TDM, fenotypizace a genotypizace pro správné dávkování léčiv. Čas Lék čes 2010; 149: 482-487.
    2. Wong G, Briscoe S, Adnan S, et al. Protein binding of β‑lactame antibiotics in critically ill patiens: Can we successfully predict unbound concentration? Antimicrob Agens Chemother 2013; 57: 6165-6170. Go to original source... Go to PubMed...
    3. Yalow RS, Berson SA. Assay of Plasma Insulin in Human Subjects by Immunological Methods. Nature 1959; 184: 1648-1649 Go to original source...
    4. Doležalová V, a kol. Laboratorní technika v klinické biochemii a toxikologii. Učební text IDVPZ Brno 1995 ISBN 80-7013-198-5.
    5. Štern P. Pokroky v imunoanalýzách s luminiscenční a elektrochemickou detekcí. Klin Bi ochem Metab 2016; 24 (45): 120-126. Go to original source...
    6. Najjar TA, Al‑Dhuwailie AA, Tekle A. Comparison of high‑performance liquid chromatogramy with fluorescence polarization immunoassay for the analysis of vancomycin inpatients with chronic renal failure. J Chromatogr B 1995; 672: 295-299. Go to original source...
    7. Safarčík K, Brozmanová H, Bartoš V, Jegorov A, Grundmann M. Evaluation and comparison of therapeutic monitoring of whole‑blood levels of cyclosporin A and its metabolites in renal transplantation by HPLC and RIA methods. Clin Chim Acta 2001; 310: 165-171. Go to original source...
    8. Soldin SJ, Steele BW, Witte DL, Wang E, Elin RJ. Lack of specificity of cyclosporine immunoassays. Arch Pathol Lab Med 2003; 127: 19-22. Go to original source...
    9. Grundmann M, Peřinová I, Brozmanová H, Kořístková B, Šafarčík K. Significant discrepancy in cyclosporin A post‑dose concentrations when analyzed with specific RIA and HPLC method. Int J Clin Pharmacol Ther 2010; 48: 87-92. Go to original source...
    10. Mei S, Wang J, Chen D, et al. Simultaneous determination of cyclosporine and tacrolimus in human whole blood by ultra‑high performance liquid chromatography tandem mass spectrometry and comparison with a chemiluminiscence microparticle immunoassay. J Chromatogr B, 2018; 1087-1088: 36-42. Go to original source...
    11. Brozmanova H, Kaciřova I, Uřinovská R, Šištík P, Grundmann M. New liquid chromatogramy‑tandem mass spectrometry method for routine TDM of vancomycin in patiens with both normal and impaired renal function and comparison with results of polarization fluoroimminoassay in light of varing creatinine concentrations. Clin. Chim. Acta 2017; 469: 136-143. Go to original source... Go to PubMed...
    12. Wiener K. A review of methods for plasma paracetamol estimation. Ann Clin Biochem 1978; 15: 187-196. Go to original source...
    13. Pavlíková L, Brozmanová H, Kvasnička F, Grundmann M, Terapeutické monitorování léků pomocí elektromigračních metod. Klin Farmakol Farm 2007; 21(2): 79-83.
    14. Budáková L, Brozmanová H, Kvasnička F, Grundmann M. Stanovení kyseliny valproové pomocí on‑line spojení izotachoforézy a kapilární zónové elektroforézy s vodivostní detekcí. Čes slov Farm 2007; 56: 249-253.
    15. Večerková J. Postupy záchytu a identifikace léčiv a jejich metabolitů v biologickém materiálu pomocí chromatografie na tenkých vrstvách. Státní pedagogické nakladatelství Praha, 1983.
    16. Dudley KH, Bius DL, Kraus BL, Boyles LW. Gas Chromatographic on-column methylation technique for the simultaneous determination of antiepileptic drugs in blood. Epilepsia 1977; 18(2): 259-286. Go to original source...
    17. Kacirova I, Grundmann M, Brozmanova H, Serum levels of valproic acid during delivery in mothers and in umbilical cord - correlation with birth length and weight Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015; 159(4): 569-575. Go to original source... Go to PubMed...
    18. Malakova J, Brozmanova H, Vorisek V, Prochazkova V, Palicka V. A capillary GC method using nitrogen phosphorus detection for determination of topiramate in patients with epilepsy. Chromatographia 2007; 66: 363-367. Go to original source...
    19. Novakova L, Douša M, a kol. Moderní HPLC separace v teorii a praxi I, Praha 2013 ISBN 978-80.260.42443-3.
    20. Rigo‑Bonnin R, Ribera A, Arbiol‑Roca, et al. Development and validation of a measurement procedure based on ultra‑high performance chromatogramy‑tandem mass spectrometry for silultaneous measurement of β‑lactam antibioc concentration in human plasma. Clin Cim Acta 2017; 468: 215-224. Go to original source...
    21. Budakova L, Brozmanova H, Grundmann M, Fischer J. Simultaneous determination of antiepileptic drugs and their two active metabolites by HPLC. J Sep Sci 2008; 31(1): 1-8. Go to original source...
    22. Schreiber‑Deturmeny E. Bruguerolle B. Simultaneous high‑performance liquid chromatographic determination of caffeine and theophylline for routine drug monitoring in human plasma. J Chromatogr B: Biomed Sci Appl 1996; 677(2) :305-312. Go to original source...
    23. Albertoni F, Rask C, Eksborg S, et al. Evaluation of clinical assays for measuring high‑dose methotrexate in plasma Clin Chem 1996; 42: 139-144. Go to original source...
    24. Rodrigues M, Alves G, Rocha M, Queiroz J, Falcão A. First liquid chromatographic method for the simultaneous determination of amiodarone and desethylamiodarone in human plasma using microextraction by packed sorbent (MEPS) as sample preparation procedure. J Chromatogr B 2013; 913-9: 90-97. Go to original source...
    25. Mercolini L, Mandrioli R, Amore M, Raggi MA. Separation and HPLC analysis of 15 benzodiazepines in human plasma. J Sep Sci 2008; 31(4): 2619-2626. Go to original source...
    26. Herbert GC, Johnstone RAW. Mass spectrometry basics. CRC Press 2003, ISBN 0-8493-1354-6.
    27. Streit F, Shipkova M, Armstrong VW, Oellerich M. Validation of a Rapid and sensitive liquid chromatography-tandem mass spectrometry method for free and total mycophenolic acid. Clin Chem 2004; 50(1): 152-159. Go to original source...
    28. Brozmanová H, Peřinová I, Halvová P, Grundmann M. Liquid chromatography‑tandem mass spectrometry method for simultaneous determination of cyclosporine A and its three primary metabolites AM1, AM9 and AM4N in whole blood and isolated lymphocytes in renal transplant patients. J Sep Sci 2010; 33(15): 2287-2293. Go to original source...
    29. Van Eeckhaut A, Lanckmans K, Sarre S, Smolders I, Michotte Y. Validation of bioanalytical LC‑MS/MS assai: evaluation of matrix effects. J Chromatogr B 2009; 877: 2198-2207. Go to original source...
    30. Chin C, Zhang ZP, Karnes HT. A study of matrix effect on an LC.MS/MS assai for olanzapine and desmethyl olanzapine, J Pharm Biomed Anal 2004; 35: 1149-1167. Go to original source...
    31. Fan Y, Peng X, Yu J, et al. An ultra‑performance liquid chromatography‑tandem mass spectrometry method to quantify vancomycin in human serum by minimizing the degradation product and matrix interference. Bioanalysis 2019; 11(10): 941-955. Go to original source... Go to PubMed...
    32. Hashi S, Nakanishi H, Masuda S, Katsurma T, Yano I. Detection of 22 antiepileptic drugs by ultra-performance liquid chromatography coupled with tandem mass spectrometry applicable to routine therapeutic drug monitoring. Biomed Chromatogr 2012; 26(12): 1519-1528. Go to original source...
    33. Hiemke C, Baumann P, Bergemann N, et al. AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011. Pharmacopsychiatry 2011; 44(6): 195-235. Go to original source...
    34. Uřinovská R, Brozmanová H, Šištík P, et al. Liquid chromatography‑tandem mass spectrometry method for determination of five antidepressants and four atypical antipsychotics and their main metabolites in human serum. J Chromatogr B Analyt Technol Biomed Life Sci 2012; 907(15): 101-107. Go to original source...
    35. Sistik P, Urinovska R, Brozmanova H, Kacirova I, Silhan P, Lemr K. Fast simultaneous LC/MS/MS determination of 10 active compounds in human serum for therapeutic drug monitoring in psychiatric medication. Biomed Chromatogr 2016; 30(2): 217-224. Go to original source... Go to PubMed...
    36. Pohanka A, Rosenborg S, Lindh JD, Beck O. Experiences from using LC‑MS/MS for analysis of immunosuppressive drugs in a TDM service. Clin Biochem 2016; 49(13-14): 1024-1031. Go to original source...
    37. Gunderon POM, Helland A, Spigset O, Hegstad S. Quantification of 21 antihypertensive drugs in serum using UHPLC‑MS/MS. J Chromatogr B 2017; 1089: 84-94. Go to original source...
    38. Xiao Y, KangXu Y, Pattengale P, O'Gorman M, Fu X. A rapid high‑performance LC- MS/MS method for therapeutic drug monitoring of voriconazole, posaconazole, fluconazole, and itraconazole in human serum. J Applied Lab Med 2017; 1(6): 626-636. Go to original source...
    39. Quaranta S, Woloch Ch, Paccou A, Giocanti M, Solas C, Lacarelle B. Validation of an electrospray ionization LC‑MS/MS method for quantitative analysis of raltegravir, etravirine, and 9 other antiretroviral agents in human plasma samples, Ther Drug Monit 2009; 31(6): 695-702. Go to original source... Go to PubMed...
    40. Vermeij TAC, Edelbroek PM. Simultaneous high‑performance liquid chromatographic analysis of pregabalin, gabapentin and vigabatrin in human serum by precolumn derivatization with o‑phtaldialdehyde and fluorescence detection, J Chromatogr B 2004; 810(2): 297-230. Go to original source...
    41. Biljeveld Y, de Haan T, Toersche J, et al. A simple quantitative method analysing amikacin, gentamicin and vancomycin levels in human newborn plasma using ion‑pair liquid chromatogpaphy/tandem mass spectrometry and its applicability to a clinical study. J Chromatogr B 2014; 951-952: 110-118. Go to original source...
    42. US Food and drug administration Guidance for industry. Bioanalytical method validation US department of health and human services, Food and drug administration, 2001.
    43. Bioanalytical Method Validation Guidance for Industry U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Veterinary Medicine (CVM), 2018.

    Return to the content


    Clinical Pharmacology and Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.